Trade GILD anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Gilead Sciences, Inc. (GILD) is trading at US$145.66, down 2.15% today as of Aug 28, 12:43 EDT. The company has a market capitalisation of US$181.18B. Over the past 52 weeks, GILD has traded between US$108.46 and US$157.29. On Syfe you can trade GILD with $0 commission and add it to your watchlist.
| Previous close | US$148.86 |
|---|---|
| Market cap | US$181.18B |
| P/E ratio | 23.04 |
| 52-week range | US$108.46 – US$157.29 |
| Dividend yield | 2.19% |
| Volume | 4.91M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Gilead Sciences, Inc.
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Year: 1992
Gilead Sciences, Inc. (GILD) stock is trading at US$145.66, -2.15% from the previous close of US$148.86.
The market cap for Gilead Sciences, Inc. (GILD) stock is approximately US$181.18B.
The price-to-earnings ratio for Gilead Sciences, Inc. (GILD) is 23.04, based on the latest reported earnings.
The 52-week high for Gilead Sciences, Inc. (GILD) stock is US$157.29.
The 52-week low for Gilead Sciences, Inc. (GILD) stock is US$108.46.
Yes, Gilead Sciences, Inc. (GILD) pays a dividend. The trailing 12-month dividend yield is 2.19%.
Stay on top of GILD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
